The Structural Disease Center

Filter Your Results




Study Supports Device Closure of PFO in Patients After Cryptogenic Stroke

March 12, 2018 -- Two-year data from the DEFENSE-PFO trial comparing device closure of patent foramen ovale (PFO) versus medical therapy for secondary prevention in cryptogeni…

Interventional Therapies for Heart Failure

Ted E. Feldman, MD, MSCAI, FACC, FESC

January/February 2018— Interventional therapies for heart failure are growing rapidly and represent a new frontier in our field. This issue is our first to focus on understanding more about inte…

Technologies for Treating Left Atrial Decompression in Heart Failure

Scott M. Lilly, MD, PhD; and Daniel Burkhoff, MD, PhD

January/February 2018—An overview of three unique devices that are currently in development, including data from early clinical trial experience and the potential advantages and pitfalls to be explored.

PFO Closure for Cryptogenic Stroke

Dominik M. Wiktor, MD; and John D. Carroll, MD

January/February 2018—Data from three randomized clinical trials offer promising results for the use of patent foramen ovale closure in the treatment of cryptogenic stroke.

BioVentrix's Revivent TC System Achieves 2018 Reimbursement in Germany

February 6, 2018 -- BioVentrix, Inc. announced that InEK, the German Institute for the Hospital Remuneration System, has reconfirmed the award of NUB Status 1 for the company&…

Boston Scientific Makes Investment in Millipede With Acquisition Option

January 24, 2018 -- Boston Scientific Corporation announced that it has closed an investment and entered into an acquisition option agreement with Millipede, Inc., a privately…

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

IDE Clinical Trial Begins for BioSense Webster's WaveCrest LAAO Device

January 11, 2018 -- Johnson & Johnson Medical Devices Companies announced that the first patient was enrolled in the WaveCrest investigational device exemption trial of th…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.